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Essential functions of ezrin in maintenance of cell shape and
lamellipodial extension in normal and transformed fibroblasts
Richard F. Lamb*, Bradford W. Ozanne*, Christian Roy†, Lynn McGarry*,
Christopher Stipp‡, Paul Mangeat† and Daniel G. Jay‡
Background: Changes in cell shape and motility are important manifestations
of oncogenic transformation, but the mechanisms underlying these changes
and key effector molecules in the cytoskeleton remain unknown. The Fos
oncogene induces expression of ezrin, the founder member of the
ezrin/radixin/moesin (ERM) protein family, but not expression of the related ERM
proteins, suggesting that ezrin has a distinct role in cell transformation. ERM
proteins have been suggested to link the plasma membrane to the actin-based
cytoskeleton and are substrates and anchoring sites for a variety of protein
kinases. Here, we examined the role of ezrin in cellular transformation.
Results: Fos-mediated transformation of Rat-1 fibroblasts resulted in an
increased expression and hyperphosphorylation of ezrin, and a concomitant
increased association of ezrin with the cortical cytoskeleton. We tagged ezrin
with green fluorescent protein and examined its distribution in normal and Fos-
transformed fibroblasts: ezrin was concentrated at the leading edge of
extending pseudopodia of Fos-transformed Rat-1 cells, and was mainly
cytosolic in normal Rat-1 cells. Functional ablation of ezrin by micro-CALI
(chromophore-assisted laser inactivation) blocked plasma-membrane ruffling
and motility of Fos-transformed fibroblasts. Ablation of ezrin in normal Rat-1
cells caused a marked collapse of the leading edge of the cell.
Conclusion: Ezrin plays an important role in pseudopodial extension in Fos-
transformed Rat-1 fibroblasts, and maintains cell shape in normal Rat-1 cells.
The increased expression, hyperphosphorylation and subcellular redistribution
of ezrin upon fibroblast transformation coupled with its roles in cell shape and
motility suggest a critical role for ezrin in oncogenic transformation.
Background
The actin-based cytoskeleton plays a central role in cell
motility and cortical morphogenesis, and is reorganized
during cell transformation [1]. Ezrin, the founder member
of the ezrin/radixin/moesin (ERM) family, has been pro-
posed to function as a molecular linker, modulating corti-
cal morphogenesis by tethering actin microfilaments to
the plasma membrane [2,3]. Ezrin expression is increased
during cellular transformation by Fos [4]; Fos family
members heterodimerise with those of the Jun family to
form AP-1 proteins, a group of transcription factors
required for oncogenic transformation [5,6].
Recent evidence indicates that a major plasma-membrane
ligand for ERM proteins might be the hyaluronan receptor
CD44 [7]. We have shown previously that CD44 expression
is regulated by AP-1 and that CD44 is required for the in
vitro invasion of Fos-transformed Rat-1 fibroblasts into
extracellular matrix [8,9]. These data suggested that ezrin
might also play an important role in motility, but a precise
role of ezrin in transformation remained unclear. In these
studies, we examined ezrin phosphorylation, the association
of ezrin with the plasma membrane and its effects on the
cytoskeleton and cell dynamics. We also examined the con-
sequences of the functional inactivation of ezrin in normal
and Fos-transformed Rat-1 fibroblasts.
Results
Transformation by Fos induces ezrin hyperphosphorylation
and relocalization
Stable transformation of Rat-1 cells by Fos led to increased
ezrin expression ([4], Figure 1a) and hyperphosphorylation
of ezrin (Figure 1b,c). Fos-induced transformation also
caused a significant enrichment of ezrin associated with the
cytoskeleton (Figure 1d,e); this enrichment did not occur in
Fos-transformed Rat-1 cells that expressed a transactiva-
tion-defective dominant-negative inhibitor of AP-1 (c-
Jun/TAM-67 [10]; Figure 1d, lanes 7–9) which inhibits
changes in shape and motility induced by Fos [9]. Addition-
ally, Fos-transformed Rat-1 cells showed a marked increase
in colocalization of ezrin with F-actin, which is concentrated
in plasma membrane ruffles at the tips of long filamentous
Addresses: *Beatson Institute for Cancer Research,
CRC Beatson Laboratories, Wolfson Laboratory for
Molecular Pathology, Garscube Estate, Switchback
Road, Bearsden, Glasgow G61 1BD, Scotland, UK.
†Dynamique Moleculaire des Interactions
Membranaires, CNRS UMR 5539, Universite
Montpellier 2, CC 107, 34095 Montpellier Cedex 5,
France. ‡ Department of Molecular and Cellular
Biology, 16 Divinity Avenue, Harvard University,
Cambridge, Massachusetts, 02138, USA.
Correspondence: Richard F. Lamb
E-mail: rlamb@ucl.ac.uk
Received: 19 May 1997
Revised: 26 June 1997
Accepted: 17 July 1997
Published: 19 August 1997
Current Biology 1997, 7:682–688
http://biomednet.com/elecref/0960982200700682
© Current Biology Ltd ISSN 0960-9822
cell processes (pseudopodia; Figure 2b, arrowheads) and in
microvilli. In normal Rat-1 cells, the majority of ezrin
immunostaining was cytosolic and did not colocalize with
F-actin (Figure 2a). 
Ezrin is associated with motile leading-edge structures in
Fos-transformed Rat-1 fibroblasts
The immunocytochemical data was confirmed by observ-
ing the dynamic cellular distribution of a fusion protein
consisting of green fluorescent protein (GFP) [11] fused to
the carboxy terminus of ezrin, creating ezrin–GFP (Figure
1a, lane 3). The distribution of ezrin–GFP was indistin-
guishable immunocytochemically from that of endogenous
ezrin and colocalized with F-actin in plasma membrane
ruffles at the tips of pseudopodia (Figure 3b, arrowheads),
and in microvilli in Fos-transformed Rat-1 cells; in normal
Rat-1 cells, ezrin–GFP was predominantly cytosolic
(Figure 3a). Time-lapse video fluorescence microscopy of
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Figure 1
Biochemical analysis of ezrin in normal and
Fos-transformed Rat-1 cells.
(a) Immunoprecipitation of p81 ezrin with anti-
ezrin IgG used for CALI; Rat-1 cells (lane 1),
Fos-transformed Rat-1 cells (lane 2), and Fos-
transformed Rat-1 cells transiently transfected
with ezrin–GFP (p110, lane 3). Quantitation
revealed that there was a 3–4-fold induction
of ezrin in Fos-transformed Rat-1 cells in
comparison to wild-type Rat-1 cells. 
(b) Immunoprecipitation of 32P-labelled ezrin
from Rat-1 cells (lane 1) or Fos-transformed
Rat-1 cells (lane 2). Quantitation revealed that
there was an 8–9-fold increase in
phosphorylation of ezrin in Fos-transformed
Rat-1 cells in comparison to wild-type Rat-1
cells. (c) Two-dimensional SDS–PAGE
immunoblot of ezrin from Rat-1 cell lysates
(upper panel) and Fos-transformed Rat-1 cell
lysates (lower panel). Asterisks indicate the
abundant phosphorylated ezrin isoforms in
Fos-transformed Rat-1 cells. (d) Immunoblot
of cell fractions representing soluble, Triton X-
100 soluble (TX-100S) and Triton X-100
insoluble (TX-100P) material from Rat-1 cells
(lanes 1–3), Fos-transformed Rat-1 cells
(lanes 4–6) and Fos-transformed Rat-1 cells
expressing TAM-67 (Fos + TAM-67, lanes
7–9) or control vector (Fos + Control, lanes
10–12) probed for ezrin expression with an
anti-ezrin antibody. The blot was also probed
with anti-transferrin receptor (anti-TfR) and
anti-vimentin antibodies to ensure enrichment
for Triton X-100 soluble and cytoskeletal
components, respectively, in the appropriate
cell fractions. (e) Quantitation of (d). Ezrin
from each cell fraction is expressed as a
percentage of all fractions, n = 3.
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ezrin–GFP revealed that a pool of fluorescence was consis-
tently associated with the plasma membrane at the mem-
brane-ruffling area of the tips of extending pseudopodia in
Fos-transformed Rat-1 cells (Figure 3d, arrowheads).
Although this fluorescence was primarily diffuse in normal
Rat-1 cells (Figure 3c), a minor pool of ezrin–GFP was
associated with dynamic phase-dark structures around the
cell periphery (Figure 3c, arrowheads). 
Ablation of ezrin by micro-CALI
To test whether ezrin functions in pseudopodial motility
in Fos-transformed Rat-1 cells, we specifically ablated
the dynamic ezrin pool present in leading lamellae using
micro-CALI (chromophore-assisted laser irradiation;
[12–14]). This technique inactivates proteins in vivo
using microinjected non-blocking antibodies conjugated
to a chromophore (malachite green, MG): upon absorp-
tion of 620 nm laser light, hydroxyl radicals are released
which then inactivate antibody-bound protein. To
confirm that CALI could inhibit the biochemical activity
of ezrin, we used a solid-phase assay that monitored the
binding of F-actin to recombinant ezrin coated on 96-
well chambers [15]. Laser irradiation selectively inhib-
ited actin binding in chambers treated with
MG-conjugated anti-ezrin antibody, but not in chambers
treated with control MG-conjugated immunoglobulin G
(IgG) antibody (Figure 4a, lanes 2,4) indicating that in
vitro CALI can inhibit the binding of ezrin to F-actin.
The anti-ezrin antibody used was monospecific for ezrin
as shown by the immunoprecipitation of a single 81 kDa
species from 35S-labelled cell lysates from Rat-1 or Fos-
transformed Rat-1 cells (Figure 1a, lanes 1,2) and by spe-
cific recognition of ezrin by western blotting analysis of
ERM proteins produced in baculovirally infected Sf9
insect cells (Figure 4b). Microinjection of the MG–anti-
ezrin antibody produced a similar staining pattern to that
revealed by immunocytochemistry (Figure 4c,d, arrow-
heads). Injection of the antibody without laser irradiation
caused no obvious effect on plasma membrane ruffling or
cell shape, because these cells resembled those that had
been microinjected with non-immune MG–IgG (Figure
5a–d and Table 1). 
Micro-CALI of ezrin in single Fos-transformed fibroblasts
at the extending leading edge of the cell resulted in a
rapid, reversible loss of pre-existing plasma-membrane
ruffles and the inhibition of further membrane ruffling.
Inhibition of plasma membrane ruffling began within the
5 minute period of irradiation (Figure 5a) before recovery
of peripheral ruffling and plasma membrane extension
after 10–15 minutes (data not shown). In Fos-transformed
Rat-1 cells, the inhibition of plasma-membrane ruffling
was accompanied by a net retraction of pseudopodia
(Figure 5a, and Table 1, p < 0.001). No significant effect
on plasma-membrane ruffling or extension of pseudo
podia was observed following micro-CALI irradiation of
Fos-transformed Rat-1 fibroblasts microinjected with
control non-immune MG–IgG (Figure 5b, Table 1,
p > 0.05). 
To investigate the role of ezrin in normal Rat-1 cells,
where it is found mainly in the cytosol, we selectively irra-
diated the cell body, avoiding irradiation at the leading
edge. Micro-CALI after microinjection of MG-labeled
anti-ezrin (Figure 5c), but not non-immune MG–IgG
(Figure 5d), resulted in a pronounced loss of shape and
rounding of the cell, characterized by a shearing at the cell
periphery leaving peripheral material and filamentous
structures attached to the substratum (Figure 5c, arrow-
heads and inset). No obvious effect on cell shape was
observed after similar laser irradiation of the cell body in
Fos-transformed Rat-1 cells (data not shown). These find-
ings suggest that ezrin might have distinct roles depend-
ing on its subcellular association.
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Figure 2
Double immunofluorescence of ezrin and F-actin in (a) Rat-1 cells and
(b) Fos-transformed Rat-1 cells. The arrowheads in (a) indicate the
minor colocalization of ezrin and F-actin at peripheral membrane ruffles
and, in (b), the major colocalization of the proteins at membrane ruffles
of pseudopodial tips. The lower panels in (b) show an enlarged
micrograph of ezrin and F-actin colocalization at leading-edge plasma-
membrane ruffles of Fos-transformed Rat-1cells. Scale bar = 25 µm.
Discussion
Few proteins associated with the cytoskeleton have been
shown to mediate the shape and locomotory changes char-
acteristic of oncogene transformation [16]. The increased
expression [4], hyperphosphorylation, and subcellular
redistribution of ezrin upon fibroblast transformation
coupled with its role is cell shape and motility in these
cells suggest that ezrin is important for these changes that
occur during oncogenic transformation. Consistent with
this proposal is the concomitant AP-1-mediated increase
in expression of the hyaluronan receptor CD44, a resident
plasma membrane ligand for ERM proteins [7], during cell
transformation and invasion [9]. Moreover, the interaction
between CD44 and ERM proteins might be regulated by
the small GTPase Rho [17], which is also necessary for
oncogenic transformation [18] and involved in controlling
the actin cytoskeleton [19].
Antisense and overexpression studies with ERM family
proteins have indicated both distinct and redundant func-
tions for ERM proteins in plasma-membrane protrusion,
substrate adhesion and the generation of cell-surface
microvilli [2,3,20–22]. The ERM proteins may also
compete for binding to a common plasma-membrane
protein [23]. It is likely that the acute nature of the loss-of-
function damage imposed by micro-CALI precludes
redundancy through the compensatory effects of other
ERM proteins [14], thereby allowing an unambiguous def-
inition of ezrin function. A small measure of micro-CALI-
induced damage may occur to radixin or moesin, if these
proteins interact with and closely contact ezrin, as has
been reported [24,25]; however, we believe this to be
unlikely because the damage caused by CALI is spatially
specific even between subunits of a small protein 
complex [26].
Conclusions
Our findings indicate that ezrin plays an important role in
plasma membrane ruffling in Fos-transformed fibroblasts
and that this function is required for the extension of
pseudopodia, the filamentous cell processes typical of trans-
formation. We suggest that putative ezrin kinases active in
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Figure 3
Localization and dynamics of ezrin–GFP. Merged immunofluoresence
micrographs of ezrin–GFP (green) and F-actin (red) in (a) Rat-1 cells
and (b) Fos-transformed Rat-1 cells. The arrowheads in (a) indicate the
colocalization of ezrin–GFP and F-actin at peripheral membrane ruffles,
and, in (b), the colocalization of the proteins at membrane ruffles of
pseudopodial tips. Fluorescence time-lapse microscopy of (c) a wild-
type Rat-1 cell, showing diffuse fluorescence with minor concentration
of ezrin–GFP in dynamic peripheral structures (arrowheads) and (d) a
Fos-transformed Rat-1 cell, showing concentration of ezrin–GFP at the
plasma membrane (arrowheads) of the extending leading edge (dotted
arrows). Experiments are representative of variable expression levels of
transfected ezrin–GFP. Time is shown in minutes; scale bar = 25 µm.
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Ablation of ezrin by CALI. (a) Immunoblot of F-actin (anti-actin, upper
panel) bound to recombinant ezrin (anti-ezrin, lower panel) in a solid-
phase assay after in vitro CALI. Lane 1, no ezrin, MG–anti-ezrin, laser
irradiation; lane 2, MG–IgG, laser irradiation; lane 3, MG–IgG, no
laser irradiation; lane 4, MG–anti-ezrin, laser irradiation; lane 5,
MG–anti-ezrin, no laser irradiation. (b) Specific recognition of ezrin
by anti-ezrin IgG. The left panel shows a Coomassie-blue-stained gel
of total Sf9 lysates from cells infected with baculoviruses producing
ezrin (E), radixin (R) or moesin (M). The right panel shows the
western blot analysis of baculovirally produced ERM proteins probed
with anti-ezrin IgG. The arrowhead indicates reactivity with ezrin. A
long exposure is shown revealing the presence of minor ezrin
breakdown products in the Sf9 lysates (arterisks), but no cross-
reactivity to either radixin or moesin. Binding of microinjected
MG–anti-ezrin IgG in (c) Rat-1cells and (d) Fos-transformed Rat-1
cells. Specific binding was observed in peripheral plasma-membrane
ruffles in Rat-1 cells (arrowheads in c) and at the leading edge in
Fos-transformed Rat-1 cells (arrowhead in d), in addition to general
cytosolic staining some of which represents non-specific retention of
antibody after fixation. The inset in (d) shows a higher magnification
of the leading edge of a Fos-transformed Rat-1 cell showing binding
of MG–anti-ezrin antibody (arrowhead).
Figure 5
Micro-CALI in vivo. Phase time-lapse images
of micro-CALI at (a,b) pseudopodial
extensions of Fos-transformed Rat-1 cells or
(c,d) in the cell body of Rat-1 cells after
microinjection with MG-labelled anti-ezrin (a,c)
or non-immune IgG (b,d). A rapid inhibition of
membrane ruffling is shown in (a) and
indicated by the arrowheads in t = –5, prior to
irradiation, at the leading edge beginning
during the period of laser irradiation (t = +5)
and persisting for 10–15 min. The arrowhead
in (a) at t = +15 indicates that there is some
recovery of plasma membrane extension. (c)
In Rat-1 cells, micro-CALI outside the cell
periphery resulted in the loss of cell
architecture, beginning 5–10 min after micro-
CALI with deposition of peripheral material
(arrowheads in (c), t = +20) and filaments
(arrowheads in the inset) on the substratum
followed by cell rounding (t = +20). Also
shown is the outline of the cell before (fine
dotted line) and after (thick dotted line) micro-
CALI. Time is shown in min, –5 = prior to
irradiation, +5 = after 5 min of laser irradiation.
In (a–d), open circles = 10 µm diameter laser
spot. Scale bar = 15 µm.
Fos-transformed Rat-1 fibroblasts might serve to unmask a
cryptic F-actin-dependent extension activity analogous to
that seen upon overexpression of an amino-terminally trun-
cated ezrin protein [21]. In Rat-1 cells, inactivation of the
cytosolic ezrin pool suggests that, despite its apparent
absence from focal adhesions [27], ezrin is required to main-
tain cell shape. We suggest that a dynamic association of
cytosolic ezrin with F-actin and/or plasma-membrane
ligands might play a role in the initiation of new focal adhe-
sions, rather than a role in the maintenance of focal adhe-
sion structure. In accord with such a proposal, another ERM
protein, moesin, has recently been shown to induce the for-
mation of integrin-containing focal complexes and adhe-
sions in quiescent Swiss 3T3 fibroblasts [28]. Inactivation of
cytosolic ezrin could prevent the initiation of new focal
adhesions, thereby rendering cell shape subject to perturba-
tion by tension during motility. Loss of adhesion/cell
rounding in Rat-1 cells resulting from the depletion of
cytosolic ezrin by micro-CALI, is also a hallmark of cell
transformation [1]. We suggest that a similar depletion of
cytosolic ezrin by hyperphosphorylation and association
with the plasma membrane or cytoskeleton might occur
during Fos-induced cell transformation.
Materials and methods
Metabolic labelling, immunoprecipitation
For metabolic labelling with [35S]-cysteine/methionine or inorganic 32P,
Rat-1 cells (208F clone) or Rat-1 cells virally transduced by the Finkel-
Biskis-Reilly (FBR) v-fos oncogene were labelled in the exponential
phase of growth with 100 µCi/ml 35S-Promix, or 1 mCi/ml inorganic
32P, (Amersham) for 4 h in DMEM/5%FCS lacking cysteine and
methionine (for 35S-labelling) or for 1 h in phosphate-free
DMEM/5%FCS (for 32P-labelling) and lysed in RIPA buffer (150 mM
NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris
pH8.0) containing 1 mM Na3VO4, 1 mM PMSF, 5 mM NaF, 1 mM β-
glycerophosphate and 1 µg/ml okadaic acid. Lysates containing
400 µg of protein were immunoprecipitated for 60 min on ice with anti-
ezrin IgG and immune complexes were collected with protein-
A–sepharose. Immunoprecipitates analysed by 10% SDS–PAGE and
dried gels were exposed to Kodak X-OMAT film. Autoradiographic
quantitation of the amount of ezrin immunoprecipitated from Rat-1 cells
or Fos-transformed Rat-1 cells or of 32P-labelled ezrin was performed
with Quantity-One software (PDI).
Two-dimensional SDS–PAGE, cell fractionation analysis 
For analysis by two-dimensional SDS–PAGE, cells were lysed in two-
dimensional sample buffer (10 M urea, 4% NP-40, 5.5% ampholytes
pH3-10/2D-optimised (Millipore), 100 mM DTT, 0.003% BPB, 1 mM
Na3VO4, 1 mM PMSF, 5 mM NaF, 1 mM β-glycerophosphate and
1 µg/ml okadaic acid), two-dimensional SDS–PAGE carried out
according to [29], and the gels were transferred to Immobilon P mem-
branes. Immunoblots were probed with anti-ezrin sera (1:10 000) and
processed and developed using the enhanced chemiluminescence
system (Amersham). A similar induction of ezrin expression and phos-
phorylation was also observed after conditional transformation of Rat-
1 cells by a c-Fos–ER fusion protein (data not shown). For
fractionation analysis, cells were homogenized in 10 mM Hepes pH
7.4, 1 mM Na3VO4, 2.5 mM MgCl2, 1 mM EGTA, 10% glycerol,
100 µg/ml CHAPS, 1 mM PMSF, and protease inhibitors (Complete,
BCL) were centrifuged (20 min, 18 000 r.p.m.), soluble material
removed, and the pellet homogenized in Triton X-100 lysis buffer
(25 mM MES pH 6.4, 1 mM Na3VO4, 2.5 mM MgCl2, 3 mM EGTA,
0.5% Triton X- 100, 10% glycerol, 1 mM PMSF, and protease
inhibitors (Complete, BCL). Triton X-100-soluble material was
removed following centrifugation (40C for 20 min at 14 000 r.p.m.)
and the remaining insoluble pellet solubilized by sonication in SDS
sample buffer. Proteins (10 µg) in each cell fraction were adjusted to
1 × sample buffer, subjected to 10% SDS–PAGE and transferred to
Immobilon-P membranes (Millipore). Immunoblots were probed with
anti-ezrin (1:10 000), anti-transferrin receptor H68.4 (1:1000) and
anti-vimentin (Sigma) antibodies. Autoradiographic quantitation was
performed using Quantity-One software (PDI) and represents the
mean of three separate experiments.
Immunofluorescence 
Immunofluorescence was performed on a Nikon Diaphot microscope
equipped with ultraviolet illumination. Anti-ezrin IgG (1:300) and
TRITC–phalloidin (1 µg/ml, Sigma) were used. FITC-labelled anti-rabbit
IgG (1:100, Jackson Immunoresearch) was used to detect bound ezrin
antibody. Cells plated on coverslips were fixed for 15 min at 37°C in
4% paraformaldehyde, washed extensively in PBS and permeabilized in
PBS/20 mM glycine/0.05% TX-100 for 5 min. Blocking of nonspecific
binding was performed for 20 min in blocking buffer (PBS/0.5% BSA
(Fraction V, Sigma)/10% FCS) before incubation for 60 min at room
temperature in the same buffer containing anti-ezrin IgG. After exten-
sive washing in blocking buffer, cells were incubated in blocking buffer
containing secondary antibody and TRITC-phalloidin for 45 min,
washed extensively in PBS and mounted (Vectashield, Vector Labora-
tories). Cells were imaged with a 100× objective (Nikon PlanApo 100)
and photographed under ultraviolet light on Ectachrome Elite 100
colour film using filter blocks for TRITC and FITC.
Construction of ezrin–GFP and fluoresence time-lapse
microscopy
Cells were plated on glass coverslips after transient transfection
(Genepulser, Biorad) with 10 µg of a construct expressing a carboxy-
terminally-tagged ezrin–GFP fusion protein. This fusion was generated
by ligating an EcoRI–SalI PCR-amplified (Pfu polymerase; Stratagene)
ezrin cDNA into pEGP-N1 (Clontech) with the following primers: 5′
primer; 5′-ACGTGAATCCCCGAAAATGCCGAAACCAATCAAT-3′;
3′ primer; 5′-ACGTGTCGACGACAGGGCCTCGAACTCGTCGAT-
3′, where the underlined sequences represent the EcoRI (5′ primer)
and Sal1 (3′ primer) restriction sites, generating the construct
pEGFPN1ezGFP. After 24 h, transfected cells were fixed and stained
with TRITC–phalloidin and projections of dual channels, green (GFP)
and red (TRITC–phalloidin) converted to TIFF images as above, or
coverslips mounted on an MRC 600 Nikon Diaphot confocal laser
microscope at 37°C in HEPES-buffered DMEM/10% FCS for fluores-
cence time-lapse microscopy. Dual phase and GFP signals at 30 sec
intervals were collected with a COMOS programme (Biorad) and
processed as TIFF images.
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Table 1
Summary of micro-CALI data: quantitative change in
pseudopodial extension in Fos-transformed Rat-1 fibroblasts
Condition MG–anti-ezrin MG–IgG
Average change in pseudopodial length (µm ± s.e.m.)
before CALI +2.01 ± 0.45 +1.85 ± 0.33
after CALI –3.63 ± 1.08* +2.02 ± 0.35
n 15 12
retraction 12/15 1/12
Measurements of change in pseudopodial length of Fos-transformed
Rat-1 captured as described [13] in the 10 min before and 10 min
after laser irradiation. Data are shown as means ± SEM. *p < 0.001
following irradiation of MG–anti-ezrin-microinjected Fos-transformed
Rat-1 by analysis of Student’s unpaired t-test. The differences between
other groups are not statistically significant by this test (p > 0.05).
In vitro actin-binding assay 
The in vitro F-actin-binding assay [15] used 0.2 µg recombinant ezrin
coated on 96-well needle-point chambers. Non-immune IgG or anti-
ezrin IgG [30] (2 µg), labelled with malachite green (MG) to similar
ratios (5–9 dyes per IgG molecule, [12]) were added to ezrin-coated or
uncoated chambers in binding buffer lacking F-actin for 1 h at room
temperature. Chambers were washed extensively in binding buffer, irra-
diated as described [12], and F-actin added in binding buffer. Bound F-
actin and ezrin were eluted from the chambers in SDS–sample buffer
and subjected to 10% SDS–PAGE. Duplicate immunoblots were
probed with anti-actin monoclonal antibody (1:100, Sigma) or anti-ezrin
sera (1:10 000).
Production of ERMs in baculovirally-infected Sf9 cells and
microinjection
ERMs were produced in baculovirally-infected Sf9 cells as described
[21]. Lysates were subjected to SDS–PAGE, stained with Coomassie
blue or transferred to Immobilon P membranes and immunoblotted with
anti-ezrin IgG and processed using the ECL system (Amersham).
TRITC-labelled anti-rabbit IgG (1:100, Sigma) was used for microinjec-
tion of MG-labelled anti-ezrin IgG (5 µg/ml) and immunofluoresence to
detect bound ezrin IgG.
Micro-CALI
Fos-transformed Rat-1 cells or Rat-1 cells, microinjected at a concen-
tration of 1 mg/ml with MG-labelled antibodies and fluorescein-dextran
(3 mg/ml, Molecular Probes) were localized after 60–90 min by epifluo-
rescence and subjected to micro-CALI. Fos-transformed Rat-1 cells
were viewed for 10–15 min with a Nikon Diaphot microscope with
phase-contrast optics to determine the direction of cell locomotion
prior to micro-CALI irradiation. Time-lapse images (one frame every
30 sec) and image enhancements were facilitated by custom-written
software [13]. Micro-CALI (10 µm diameter laser spot) was performed
for 5 min, followed by an additional 20–180 min observation period.
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